Dose fractionation of CAR-T cells. A systematic review of clinical outcomes

CAR-T cells are widely recognized for their potential to successfully treat hematologic cancers and provide durable response. However, severe adverse events such as cytokine release syndrome (CRS) and neurotoxicity are concerning. Our goal is to assess CAR-T cell clinical trial publications to addre...

Descripción completa

Detalles Bibliográficos
Autores principales: Frigault, Matthew, Rotte, Anand, Ansari, Ayub, Gliner, Bradford, Heery, Christopher, Shah, Bijal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830795/
https://www.ncbi.nlm.nih.gov/pubmed/36627710
http://dx.doi.org/10.1186/s13046-022-02540-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830795/
https://www.ncbi.nlm.nih.gov/pubmed/36627710
http://dx.doi.org/10.1186/s13046-022-02540-w

Ejemplares similares